Disputed COVID-19 trial failure reports send Gilead shares d...

Gilead's COVID-19 drug remdesivir seemingly failed to produce an effect according to results of a Chinese clinical trial posted inadvertently on the World Health Organizatio

Gilead shares jump after rethink of COVID-19 remdesivir tria...

Shares in Gilead were up in premarket trading after the company announced it had increased the size of its trials for its COVID-19 drug remdesivir.

Gilead slides as second Chinese trial of remdesivir is stopp...

First study of Gilead’s remdesivir in COVID-19 reveals littl...

EMA clears compassionate use of Gilead’s remdesivir for COVI...

Gilead halts 'compassionate use' of potential coronavirus dr...

Gilead has said it has stopped accepting “compassionate use” requests for its potential coronavirus antiviral remdesivir because it cannot keep pace with demand as health systems become ove